| Product Code: ETC6745444 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
China insulin syringe import market in 2024 continued to see a diverse range of suppliers, with Switzerland, USA, Mexico, Germany, and Austria emerging as the top exporting countries. The market displayed low concentration with a Herfindahl-Hirschman Index (HHI) indicating healthy competition. The compound annual growth rate (CAGR) from 2020 to 2024 stood at 5.55%, while the growth rate from 2023 to 2024 surged to 8.67%, reflecting a strong upward trend in demand and shipments of insulin syringes into China.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Insulin Syringe Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Insulin Syringe Market Revenues & Volume, 2021 & 2031F |
3.3 China Insulin Syringe Market - Industry Life Cycle |
3.4 China Insulin Syringe Market - Porter's Five Forces |
3.5 China Insulin Syringe Market Revenues & Volume Share, By Syringe Size, 2021 & 2031F |
3.6 China Insulin Syringe Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 China Insulin Syringe Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Insulin Syringe Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in China |
4.2.2 Growing awareness about diabetes management and treatment |
4.2.3 Technological advancements in insulin syringe design and manufacturing |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for insulin syringe manufacturing and distribution |
4.3.2 Competition from alternative drug delivery methods such as insulin pens |
4.3.3 Price sensitivity among consumers in China |
5 China Insulin Syringe Market Trends |
6 China Insulin Syringe Market, By Types |
6.1 China Insulin Syringe Market, By Syringe Size |
6.1.1 Overview and Analysis |
6.1.2 China Insulin Syringe Market Revenues & Volume, By Syringe Size, 2021- 2031F |
6.1.3 China Insulin Syringe Market Revenues & Volume, By 3/10 CC Syringe (0.3ml), 2021- 2031F |
6.1.4 China Insulin Syringe Market Revenues & Volume, By 1/2 CC Syringe (0.5ml), 2021- 2031F |
6.1.5 China Insulin Syringe Market Revenues & Volume, By 1CC Syringe (1ml), 2021- 2031F |
6.1.6 China Insulin Syringe Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Insulin Syringe Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 China Insulin Syringe Market Revenues & Volume, By Type 1 Diabetes, 2021- 2031F |
6.2.3 China Insulin Syringe Market Revenues & Volume, By Type 2 Diabetes, 2021- 2031F |
6.3 China Insulin Syringe Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 China Insulin Syringe Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.3.3 China Insulin Syringe Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
6.3.4 China Insulin Syringe Market Revenues & Volume, By Others, 2021- 2031F |
7 China Insulin Syringe Market Import-Export Trade Statistics |
7.1 China Insulin Syringe Market Export to Major Countries |
7.2 China Insulin Syringe Market Imports from Major Countries |
8 China Insulin Syringe Market Key Performance Indicators |
8.1 Adoption rate of advanced insulin syringe technologies |
8.2 Number of diabetes education programs conducted in China |
8.3 Rate of compliance with insulin therapy guidelines |
9 China Insulin Syringe Market - Opportunity Assessment |
9.1 China Insulin Syringe Market Opportunity Assessment, By Syringe Size, 2021 & 2031F |
9.2 China Insulin Syringe Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.3 China Insulin Syringe Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Insulin Syringe Market - Competitive Landscape |
10.1 China Insulin Syringe Market Revenue Share, By Companies, 2024 |
10.2 China Insulin Syringe Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |